LevEllis Strengthens Executive Team to Scale Regenerative Skin Platform

Pedroza joins the company following a 14-year tenure at ZO Skin Health, where she served as Senior Vice President of Global Marketing. Her mandate includes overseeing U.S. and international commercial strategy, e-commerce, and provider advocacy. Patrick, a veteran with over two decades in medical aesthetics, arrives from ALASTIN Skincare. In her new role, she will manage national sales strategy and field execution, focusing on the education-driven approach required to bring the company’s secretome-based technology to professional channels.

Founder and CEO Dr. Laura Ellis describes the company’s trajectory as a shift toward treating skin as a coordinated biological system rather than a collection of isolated signals. The firm’s core technology, PROVOQUE, utilizes a secretome derived from skin progenitor cells. This expansion of the management team is intended to align the company's organizational infrastructure with its scientific ambitions, supported by a multidisciplinary advisory board that includes experts in stem-cell biology and regenerative medicine like Hans S. Keirstead and Dr. Julie Ann Woodward.